These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet? Singh SP; Barik RK J Clin Exp Hepatol; 2020; 10(1):88-98. PubMed ID: 32025168 [TBL] [Abstract][Full Text] [Related]
4. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver. Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994 [TBL] [Abstract][Full Text] [Related]
5. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Castera L; Friedrich-Rust M; Loomba R Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]
8. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. Mayo R; Crespo J; Martínez-Arranz I; Banales JM; Arias M; Mincholé I; Aller de la Fuente R; Jimenez-Agüero R; Alonso C; de Luis DA; Vitek L; Stritesky J; Caballería J; Romero-Gómez M; Martín-Duce A; Mugüerza Huguet JM; Busteros-Moraza JI; Idowu MO; Castro A; Martínez-Chantar ML; Ortiz P; Bruha R; Lu SC; Bedossa P; Noureddin M; Sanyal AJ; Mato JM Hepatol Commun; 2018 Jul; 2(7):807-820. PubMed ID: 30027139 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions. Kadi D; Loomba R; Bashir MR Radiology; 2024 Jan; 310(1):e222695. PubMed ID: 38226882 [TBL] [Abstract][Full Text] [Related]
10. Pathology of nonalcoholic steatohepatitis. Brunt EM Hepatol Res; 2005 Oct; 33(2):68-71. PubMed ID: 16214395 [TBL] [Abstract][Full Text] [Related]
11. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort. Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378 [TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis markers of nonalcoholic steatohepatitis. Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553 [TBL] [Abstract][Full Text] [Related]
15. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Drescher HK; Weiskirchen S; Weiskirchen R Cells; 2019 Aug; 8(8):. PubMed ID: 31394730 [TBL] [Abstract][Full Text] [Related]
16. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort. De A; Keisham A; Mishra S; Mehta M; Verma N; Premkumar M; Taneja S; Das A; Singh V; Duseja A J Clin Exp Hepatol; 2022; 12(2):440-447. PubMed ID: 35535068 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease. Jayasekera D; Hartmann P World J Hepatol; 2023 May; 15(5):609-640. PubMed ID: 37305367 [TBL] [Abstract][Full Text] [Related]
18. Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet? Arulanandan A; Loomba R Curr Hepatol Rep; 2015 Jun; 14(2):109-118. PubMed ID: 26500833 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Wong T; Wong RJ; Gish RG Gastroenterol Hepatol (N Y); 2019 Feb; 15(2):83-89. PubMed ID: 31011302 [TBL] [Abstract][Full Text] [Related]
20. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver. De A; Duseja A J Clin Exp Hepatol; 2020; 10(3):255-262. PubMed ID: 32405182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]